Previous Page  8 / 32 Next Page
Information
Show Menu
Previous Page 8 / 32 Next Page
Page Background

COMMENT

By Joerg Herrmann

MD

T

his study is an important contribution

even though only 31 patients were

included. This is half the cohort of

patients currently in the DISRUPT CAD

program on a novel mode of percutane-

ous intervention: coronary lithoplasty. The

terminology is noteworthy. This is not litho-

tripsy, which is pure shockwave therapy. It is

lithoplasty; that is, with an element of angi-

oplasty. Indeed, the coronary lithoplasty

catheter is a balloon angioplasty cath-

eter that contains a series of unfocused

electrohydraulic lithotripsy emitters. The

balloon is advanced to the lesion, inflated

to 4 atm (to unfold), and 10 pulses are deliv-

ered (ie, lithotripsy). This is then followed

by further dilation to nominal pressures

and reference vessel size (ie, angioplasty).

The procedure is repeated for a mini-

mum of 20 pulses. Of further note, OCT

was performed before lithotripsy, requir-

ing predilation in 20% of the cases. Given

these elements of angioplasty involved,

the acute gain in luminal dimensions can-

not be attributed to lithotripsy effects alone.

One may even argue that the modification

effects on calcium thickness and calcium

angle were not very prominent, even with

94 pulses on average.

However, the goal is more the fragmenta-

tion into pieces, or, better stated, fractures

into the planes of coronary artery calcifi-

cation. Calcium fractures were noted in

nearly 50% of cases and circumferential

multiple fractures in 25%. These numbers

were not significantly increased by stent

implantation. These observations may

thus argue in favor of a lithotripsy effect

and sufficient improvement of lesion com-

pliance. Importantly, these effects were

more pronounced with increasing calcifi-

cation severity, and an effect was noted

irrespective of depth within the vessel.

This being said, OCT is not as sound as

IVUS to visualize coronary calcifications,

especially those of deeper location.

Nevertheless, these are important dis-

tinguishing features from the effects of

rotational and orbital atherectomy, which

cannot modify deep-seated calcium. In

further distinction, lithotripsy does not pul-

verize or abrade the plaque, with distal

microembolization risk, or entail a guide-

wire bias that leads to asymmetry and

eccentricity of the effect in some lesions,

and laceration and dissections in others.

Thus, the effect is more uniform and the

device is safe; the only complications are

related to dissections caused by the angi-

oplasty component.

All of this being said, the real effect and

differential impact of this new technology

cannot be judged until appropriate

comparison studies are done. As the

effect is largely an enhancement of

balloon angioplasty effects, comparison

with plain old balloon angioplasty would

be the first step, then other plaque

calcium-modifying strategies, such as

the mentioned atherectomy options. Only

then will we really know how useful of an

adjunct this procedure is. The current

data, however, are an important step in

this direction. They provide the necessary

feasibility and safety data to proceed.

Coronary lithoplasty, here I come.

Dr Herrmann is Associate

Professor of Medicine,

Mayo Graduate School of

Medicine, Rochester,

Minnesota.

Optical Coherence Tomography

Characterization of Coronary Lithoplasty for

Treatment of Calcified Lesions

JACC: Cardiovascular Imaging

Take-home message

Optical coherence tomography (OCT) findings were evaluated in 31 patients with

severely calcified stenotic coronary lesions treated with lithoplasty prior to stent

implantation. Intraplaque calcium fracture following lithoplasty was seen in 43% of

lesions, and circumferential multiple fractures were seen in >25% of lesions. The

most severely calcified plaques showed the highest frequency of calcium fractures

per lesion. The mean acute gain in area after lithoplasty was 2.1 mm

2

and stent

implantation increased this further to a maximal stent area of 5.94 mm

2

. Mean stent

expansion was 112.0%. Deep dissection was seen in 13% of cases, and all were

successfully treated with stent implantation.

The main mechanism of action of lithoplasty is to cause intraplaque calcium frac-

tures and hence gain increased area, which facilitates stent expansion.

Abstract

OBJECTIVES

This study sought to determine the

mechanistic effects of a novel balloon-based

lithoplasty system on heavily calcified coronary

lesions and subsequent stent placement using

optical coherence tomography (OCT).

BACKGROUND

The ShockwaveCoronary Rx Lithop-

lasty System (Shockwave Medical, Fremont,

California) delivers localized, lithotripsy-enhanced

disruption of calcium within the target lesion (i.e.,

lithoplasty) for vessel preparation before stent

implantation.

METHODS

We analyzed OCT findings in 31

patients in whom lithoplasty was used to treat

severely calcified stenotic coronary lesions.

RESULTS

After lithoplasty, intraplaque calcium

fracture was identified in 43% of lesions, with

circumferential multiple fractures noted in >25%.

The frequency of calcium fractures per lesion

increased in the most severely calcified plaques

(highest tertile vs. lowest tertile; p = 0.009), with

a trend toward greater incidence of calcium frac-

ture (77.8% vs. 22.2%; p = 0.057). Post-lithoplasty,

mean acute area gain was 2.1 mm(2), which fur-

ther increasedwith stent implantation, achieving a

minimal stent area of 5.94 ± 1.98 mm(2) and mean

stent expansion of 112.0 ± 37.2%. Deep dissec-

tions, as part of the angioplasty effect, occurred in

13% of cases and were successfully treated with

stent implantation without incidence of acute clo-

sure, slow flow/no reflow, or perforation.

CONCLUSIONS

High-resolution imaging by OCT

delineated calcium modification with fracture as

a major mechanism of action of lithoplasty in vivo

and demonstrated efficacy in the achievement

of significant acute area gain and favorable stent

expansion.

Optical coherence tomography characteriza-

tion of coronary lithoplasty for treatment of

calcified lesions: first description.

JACC Car-

diovasc Imaging

2017 Aug 01;10(8)897-906, ZA

Ali, TJ Brinton, JM Hill, et al.

www.practiceupdate.com/c/56930

EDITOR’S PICKS

8

PRACTICEUPDATE CARDIOLOGY